Lupin公司以190万欧元获得荷兰眼科护理公司VISUfarma,以扩大其欧洲专业组合。 Lupin acquires Dutch eye care firm VISUfarma for €190M to expand its European specialty portfolio.

Lupin的子公司Nanomi BV同意以1.9亿欧元购买荷兰眼科公司VISUFARMA, 由现有现金供资,到2025年底结账。 Lupin's subsidiary Nanomi BV has agreed to acquire Dutch ophthalmology company VISUfarma for €190 million, to be funded with existing cash and closing by end-2025. 包括英国、德国、法国、西班牙、意大利等主要市场, 增加60多种有品牌的眼科护理产品, 例如干眼和青光眼。 The deal expands Lupin’s specialty portfolio in Europe, adding over 60 branded eye care products for conditions like dry eye and glaucoma across key markets including the UK, Germany, France, Spain, and Italy. 预计这笔收购将促进增长和利,与Lupin的战略保持一致,以多元化更高利的治疗方法,因为人口老龄化和糖尿病相关的眼病需求不断增加. The acquisition is expected to boost growth and margins, aligning with Lupin’s strategy to diversify into higher-margin therapies amid rising demand from aging populations and diabetes-related eye diseases.